View record

Novel synthetic process and formulation development of ELIGLUSTAT tartrate for treatment of GD-1
Temp 1

DST
June 6, 2023

None
None

Gaucher disease type 1
In vitro study

Quantitative data
• Proposing shortest route with two innovative steps to complete the synthesis of Eligustat molecule

Eliglustat tartrate, gaucher disease type-1, photocatalytic
None

None


Dr. Y. V. Madhavi/None/NIPER Hyderabad